
Tirzepatide (TR10 / 10mg)
Analytical grade Tirzepatide research vial with validated HPLC chromatogram.

High-purity dual agonist research standard in sealed 5mg sterile vial.
Laboratory Research Disclaimer: This chemical compound is sold strictly for analytical, in vitro, and laboratory research investigations. Not approved for human or veterinary administration.
Certified analytical research vials in 5 verified packaging specifications. Direct B2B batch allocation available.
| Cat. No | Configuration / Name | Packaging Spec | Purity / QC | Stock Status | Actions |
|---|---|---|---|---|---|
| TR5 | Tirzepatide 5mg (TR5) | 5mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR10 | Tirzepatide 10mg (TR10) | 10mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR15 | Tirzepatide 15mg (TR15) | 15mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR20 | Tirzepatide 20mg (TR20) | 20mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR30 | Tirzepatide 30mg (TR30) | 30mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) |
Tirzepatide is a novel synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor co-agonist designed for rigorous scientific laboratory investigations.
Reconstitution & Stability Guidance: Lyophilized peptides should be equilibrated to room temperature before reconstitution. Spin vial gently to ensure all powder is at the bottom. Reconstitute using sterile bacteriostatic or deionized water according to your experimental protocol. Reconstituted solutions should be aliquoted to avoid repeated freeze-thaw cycles and maintained at -20°C or below.

Analytical grade Tirzepatide research vial with validated HPLC chromatogram.

Dual GIP/GLP-1 receptor co-agonist peptide standard for laboratory studies.

High-dose research vial certified by electrospray ionization mass spectrometry.